Astrana Health (ASTH) Equity Income (2017 - 2026)

Astrana Health has disclosed Equity Income across 10 years of filings, most recently posting $1.7 million for Q1 2026.

• Equity Income for Q1 2026 came in at $1.7 million, up 298.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (up 44.51% YoY), and the FY2025 annual result was $1.7 million, down 61.63% from the prior year.
• Equity Income came in at $1.7 million for Q1 2026 at Astrana Health, up from $1.2 million in the prior quarter.
• In the past five years, Equity Income ranged from a high of $2.7 million in Q2 2023 to a low of -$2.1 million in Q3 2023.
• The 5-year median for Equity Income is $1.4 million (2024), against an average of $1.1 million.
• Across the five-year window, Equity Income jumped 311.67% in 2022 and plunged 244.9% in 2023, its largest moves.
• Astrana Health's Equity Income stood at $1.2 million in 2022, then surged by 102.04% to $2.5 million in 2023, then plunged by 37.33% to $1.6 million in 2024, then fell by 24.18% to $1.2 million in 2025, then surged by 46.26% to $1.7 million in 2026.
• The last three Equity Income figures came in at $1.7 million (Q1 2026), $1.2 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.